Literature DB >> 20930077

Melanized fungi in human disease.

Sanjay G Revankar1, Deanna A Sutton.   

Abstract

Melanized or dematiaceous fungi are associated with a wide variety of infectious syndromes, including chromoblastomycosis, mycetoma, and phaeohyphomycosis. [corrected]. Many are soil organisms and are generally distributed worldwide, though certain species appear to have restricted geographic ranges. Though they are uncommon causes of disease, melanized fungi have been increasingly recognized as important pathogens, with most reports occurring in the past 20 years. The spectrum of diseases with which they are associated has also broadened and includes allergic disease, superficial and deep local infections, pneumonia, brain abscess, and disseminated infection. For some infections in immunocompetent individuals, such as allergic fungal sinusitis and brain abscess, they are among the most common etiologic fungi. Melanin is a likely virulence factor for these fungi. Diagnosis relies on careful microscopic and pathological examination, as well as clinical assessment of the patient, as these fungi are often considered contaminants. Therapy varies depending upon the clinical syndrome. Local infection may be cured with excision alone, while systemic disease is often refractory to therapy. Triazoles such as voriconazole, posaconazole, and itraconazole have the most consistent in vitro activity. Further studies are needed to better understand the pathogenesis and optimal treatment of these uncommon infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20930077      PMCID: PMC2952981          DOI: 10.1128/CMR.00019-10

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  769 in total

1.  Invasive sinusitis and cerebritis due to Curvularia clavata in an immunocompetent adult.

Authors:  J R Ebright; P H Chandrasekar; S Marks; M R Fairfax; A Aneziokoro; M R McGinnis
Journal:  Clin Infect Dis       Date:  1999-03       Impact factor: 9.079

Review 2.  Scedosporium inflatum: first case report of disseminated infection and review of the literature.

Authors:  S A Sparrow; L A Hallam; B E Wild; D L Baker
Journal:  Pediatr Hematol Oncol       Date:  1992 Jul-Sep       Impact factor: 1.969

3.  A comparison of calcofluor white, potassium hydroxide, and culture for the laboratory diagnosis of superficial fungal infection.

Authors:  D J Haldane; E Robart
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Jul-Aug       Impact factor: 2.803

Review 4.  Phaeohyphomycosis.

Authors:  M G Rinaldi
Journal:  Dermatol Clin       Date:  1996-01       Impact factor: 3.478

Review 5.  Primary cutaneous phaeohyphomycosis: report of seven cases.

Authors:  S G Ronan; I Uzoaru; V Nadimpalli; J Guitart; J R Manaligod
Journal:  J Cutan Pathol       Date:  1993-06       Impact factor: 1.587

6.  Infections due to Wangiella dermatitidis in humans: report of the first documented case from the United States and a review of the literature.

Authors:  P E Hohl; H P Holley; E Prevost; L Ajello; A A Padhye
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

7.  Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.

Authors:  Tânia S Andrade; Luiz G M Castro; Ricardo S Nunes; Viviane M F Gimenes; Arlete E Cury
Journal:  Mycoses       Date:  2004-06       Impact factor: 4.377

8.  Systemic fungal infections in Thailand.

Authors:  P Imwidthaya
Journal:  J Med Vet Mycol       Date:  1994

9.  Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa.

Authors:  M Arango; C Jaramillo; A Cortés; A Restrepo
Journal:  Med Mycol       Date:  1998-02       Impact factor: 4.076

10.  Primary mycetoma osteomyelitis of the calcaneus with active subcutaneous nodules.

Authors:  Daniel K Lee; Alexandra K Schwartz
Journal:  J Foot Ankle Surg       Date:  2007 Jul-Aug       Impact factor: 1.286

View more
  156 in total

1.  In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.

Authors:  Anuradha Chowdhary; Ferry Hagen; Ilse Curfs-Breuker; Hugo Madrid; G Sybren de Hoog; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

2.  Fungal Planet description sheets: 716-784.

Authors:  P W Crous; M J Wingfield; T I Burgess; G E St J Hardy; J Gené; J Guarro; I G Baseia; D García; L F P Gusmão; C M Souza-Motta; R Thangavel; S Adamčík; A Barili; C W Barnes; J D P Bezerra; J J Bordallo; J F Cano-Lira; R J V de Oliveira; E Ercole; V Hubka; I Iturrieta-González; A Kubátová; M P Martín; P-A Moreau; A Morte; M E Ordoñez; A Rodríguez; A M Stchigel; A Vizzini; J Abdollahzadeh; V P Abreu; K Adamčíková; G M R Albuquerque; A V Alexandrova; E Álvarez Duarte; C Armstrong-Cho; S Banniza; R N Barbosa; J-M Bellanger; J L Bezerra; T S Cabral; M Caboň; E Caicedo; T Cantillo; A J Carnegie; L T Carmo; R F Castañeda-Ruiz; C R Clement; A Čmoková; L B Conceição; R H S F Cruz; U Damm; B D B da Silva; G A da Silva; R M F da Silva; A L C M de A Santiago; L F de Oliveira; C A F de Souza; F Déniel; B Dima; G Dong; J Edwards; C R Félix; J Fournier; T B Gibertoni; K Hosaka; T Iturriaga; M Jadan; J-L Jany; Ž Jurjević; M Kolařík; I Kušan; M F Landell; T R Leite Cordeiro; D X Lima; M Loizides; S Luo; A R Machado; H Madrid; O M C Magalhães; P Marinho; N Matočec; A Mešić; A N Miller; O V Morozova; R P Neves; K Nonaka; A Nováková; N H Oberlies; J R C Oliveira-Filho; T G L Oliveira; V Papp; O L Pereira; G Perrone; S W Peterson; T H G Pham; H A Raja; D B Raudabaugh; J Řehulka; E Rodríguez-Andrade; M Saba; A Schauflerová; R G Shivas; G Simonini; J P Z Siqueira; J O Sousa; V Stajsic; T Svetasheva; Y P Tan; Z Tkalčec; S Ullah; P Valente; N Valenzuela-Lopez; M Abrinbana; D A Viana Marques; P T W Wong; V Xavier de Lima; J Z Groenewald
Journal:  Persoonia       Date:  2018-07-13       Impact factor: 11.051

3.  Fungal disease following contaminated steroid injections: Exserohilum is ready for its close-up.

Authors:  Marta Feldmesser
Journal:  Am J Pathol       Date:  2013-07-19       Impact factor: 4.307

4.  In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.

Authors:  M J Najafzadeh; M Saradeghi Keisari; V A Vicente; P Feng; S A A Shamsian; A Rezaei-Matehkolaei; G S de Hoog; I Curfs-Breuker; J F Meis
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

5.  Ochroconis humicola coexisting with esthesioneuroblastoma: an incidental coloniser or allergen?

Authors:  Harsimran Kaur; Shivaprakash M Rudramurthy; Satyawati Mohindra; Sunita Gupta; Arunaloke Chakrabarti
Journal:  Mycopathologia       Date:  2014-06-21       Impact factor: 2.574

6.  Fatal cerebral phaeohyphomycosis in an immunocompetent individual due to Thielavia subthermophila.

Authors:  Hamid Badali; Jagdish Chander; Ashish Gupta; Hena Rani; Rajpal Singh Punia; G Sybren De Hoog; Jacques F Meis
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

7.  Application of a broad-range resequencing array for detection of pathogens in desert dust samples from Kuwait and Iraq.

Authors:  Tomasz A Leski; Anthony P Malanoski; Michael J Gregory; Baochuan Lin; David A Stenger
Journal:  Appl Environ Microbiol       Date:  2011-05-13       Impact factor: 4.792

Review 8.  Black yeasts and their filamentous relatives: principles of pathogenesis and host defense.

Authors:  Seyedmojtaba Seyedmousavi; Mihai G Netea; Johan W Mouton; Willem J G Melchers; Paul E Verweij; G Sybren de Hoog
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

9.  Logistic regression models for predicting daily airborne Alternaria and Cladosporium concentration levels in Catalonia (NE Spain).

Authors:  Andrés M Vélez-Pereira; Concepción De Linares; Miguel-Angel Canela; Jordina Belmonte
Journal:  Int J Biometeorol       Date:  2019-08-03       Impact factor: 3.787

10.  Alternaria scalp infection in a patient with alopecia areata. Coexistence or causative relationship?

Authors:  Lidia Rudnicka; Malgorzata Lukomska
Journal:  J Dermatol Case Rep       Date:  2012-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.